Literature DB >> 23081702

Animal models of leukemia: any closer to the real thing?

Guerry J Cook1, Timothy S Pardee.   

Abstract

Animal models have been invaluable in the efforts to better understand and ultimately treat patients suffering from leukemia. While important insights have been gleaned from these models, limitations must be acknowledged. In this review, we will highlight the various animal models of leukemia and describe their contributions to the improved understanding and treatment of these cancers.

Entities:  

Mesh:

Year:  2013        PMID: 23081702      PMCID: PMC3568447          DOI: 10.1007/s10555-012-9405-5

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  138 in total

1.  Observations on the effect of a folic-acid antagonist on transplantable lymphoid leukemias in mice.

Authors:  L W LAW; T B DUNN
Journal:  J Natl Cancer Inst       Date:  1949-08       Impact factor: 13.506

2.  Leukemia-initiating cells in human T-lymphoblastic leukemia exhibit glucocorticoid resistance.

Authors:  Priscilla P L Chiu; Hong Jiang; John E Dick
Journal:  Blood       Date:  2010-09-01       Impact factor: 22.113

3.  Inter-chromosomal recombination of Mll and Af9 genes mediated by cre-loxP in mouse development.

Authors:  E C Collins; R Pannell; E M Simpson; A Forster; T H Rabbitts
Journal:  EMBO Rep       Date:  2000-08       Impact factor: 8.807

4.  Analysis of the role of AML1-ETO in leukemogenesis, using an inducible transgenic mouse model.

Authors:  K L Rhoades; C J Hetherington; N Harakawa; D A Yergeau; L Zhou; L Q Liu; M T Little; D G Tenen; D E Zhang
Journal:  Blood       Date:  2000-09-15       Impact factor: 22.113

5.  Knock-in of a FLT3/ITD mutation cooperates with a NUP98-HOXD13 fusion to generate acute myeloid leukemia in a mouse model.

Authors:  Sarah Greenblatt; Li Li; Christopher Slape; Bao Nguyen; Rachel Novak; Amy Duffield; David Huso; Stephen Desiderio; Michael J Borowitz; Peter Aplan; Donald Small
Journal:  Blood       Date:  2012-02-08       Impact factor: 22.113

6.  Suppression of Philadelphia1 leukemia cell growth in mice by BCR-ABL antisense oligodeoxynucleotide.

Authors:  T Skorski; M Nieborowska-Skorska; N C Nicolaides; C Szczylik; P Iversen; R V Iozzo; G Zon; B Calabretta
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

7.  Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100.

Authors:  Bruno Nervi; Pablo Ramirez; Michael P Rettig; Geoffrey L Uy; Matthew S Holt; Julie K Ritchey; Julie L Prior; David Piwnica-Worms; Gary Bridger; Timothy J Ley; John F DiPersio
Journal:  Blood       Date:  2008-12-02       Impact factor: 22.113

8.  The biologic properties of leukemias arising from BCR/ABL-mediated transformation vary as a function of developmental origin and activity of the p19ARF gene.

Authors:  Pin-Yi Wang; Fay Young; Chun-Yu Chen; Brett M Stevens; Sarah J Neering; Randall M Rossi; Timothy Bushnell; Igor Kuzin; David Heinrich; Andrea Bottaro; Craig T Jordan
Journal:  Blood       Date:  2008-08-28       Impact factor: 22.113

9.  TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms.

Authors:  L W Ellisen; J Bird; D C West; A L Soreng; T C Reynolds; S D Smith; J Sklar
Journal:  Cell       Date:  1991-08-23       Impact factor: 41.582

10.  The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells.

Authors:  A W Harris; C A Pinkert; M Crawford; W Y Langdon; R L Brinster; J M Adams
Journal:  J Exp Med       Date:  1988-02-01       Impact factor: 14.307

View more
  20 in total

1.  Interleukin-15 deficiency promotes the development of T-cell acute lymphoblastic leukemia in non-obese diabetes mice with severe combined immunodeficiency.

Authors:  D Bobbala; R Kandhi; X Chen; M Mayhue; E Bouchard; J Yan; H Knecht; F Barabé; S Ramanathan; S Ilangumaran
Journal:  Leukemia       Date:  2016-02-15       Impact factor: 11.528

2.  Mechanism and Function of Angiogenin in Hematopoietic Malignancy.

Authors:  Kevin A Goncalves; Guo-Fu Hu
Journal:  Zhongguo Sheng Wu Hua Xue Yu Fen Zi Sheng Wu Xue Bao       Date:  2015-12-23

Review 3.  Fine-tuning patient-derived xenograft models for precision medicine approaches in leukemia.

Authors:  Olivia L Francis; Terry-Ann M Milford; Cornelia Beldiman; Kimberly J Payne
Journal:  J Investig Med       Date:  2016-02-12       Impact factor: 2.895

4.  Modeling mixed-lineage-rearranged leukemia initiation in CD34+ cells: a "CRISPR" solution.

Authors:  Raúl Torres-Ruiz; Sandra Rodriguez-Perales; Clara Bueno; Pablo Menendez
Journal:  Haematologica       Date:  2017-09       Impact factor: 9.941

5.  Constitutive Ras signaling and Ink4a/Arf inactivation cooperate during the development of B-ALL in mice.

Authors:  Tomasz Sewastianik; Meng Jiang; Kumar Sukhdeo; Sanjay S Patel; Kathryn Roberts; Yue Kang; Ahmad Alduaij; Peter S Dennis; Brian Lawney; Ruiyang Liu; Zeyuan Song; Jessie Xiong; Yunyu Zhang; Madeleine E Lemieux; Geraldine S Pinkus; Jeremy N Rich; David M Weinstock; Charles G Mullighan; Norman E Sharpless; Ruben D Carrasco
Journal:  Blood Adv       Date:  2017-11-21

6.  Comparative utility of NRG and NRGS mice for the study of normal hematopoiesis, leukemogenesis, and therapeutic response.

Authors:  Aditya Barve; Lavona Casson; Maxwell Krem; Mark Wunderlich; James C Mulloy; Levi J Beverly
Journal:  Exp Hematol       Date:  2018-08-17       Impact factor: 3.084

Review 7.  In Vitro and In Vivo Modeling of Normal and Leukemic Bone Marrow Niches: Cellular Senescence Contribution to Leukemia Induction and Progression.

Authors:  Myriam Janeth Salazar-Terreros; Jean-Paul Vernot
Journal:  Int J Mol Sci       Date:  2022-07-01       Impact factor: 6.208

8.  IL-15/IL-15Rα/CD80-expressing AML cell vaccines eradicate minimal residual disease in leukemic mice.

Authors:  Yimin Shi; Lillia Dincheva-Vogel; Charles E Ayemoba; Jeffrey P Fung; Cristina Bergamaschi; George N Pavlakis; Farzin Farzaneh; Karin M L Gaensler
Journal:  Blood Adv       Date:  2018-11-27

Review 9.  Identifying novel therapeutic agents using xenograft models of pediatric cancer.

Authors:  Raushan T Kurmasheva; Peter J Houghton
Journal:  Cancer Chemother Pharmacol       Date:  2016-05-18       Impact factor: 3.333

10.  3D models of the bone marrow in health and disease: yesterday, today and tomorrow.

Authors:  Annamarija Raic; Toufik Naolou; Anna Mohra; Chandralekha Chatterjee; Cornelia Lee-Thedieck
Journal:  MRS Commun       Date:  2018-09-25       Impact factor: 2.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.